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Background: Deleterious effects of prenatal tobacco smoking on fetal growth and newborn weight are well-established.
One of the proposed mechanisms underlying this relationship is alterations in epigenetic programming. We selected 506
newborns from a population-based prospective birth cohort in the Netherlands. Prenatal parental tobacco smoking was
assessed using self-reporting questionnaires. Information on birth outcomes was obtained from medical records. The
deoxyribonucleic acid (DNA) methylation of the growth genes IGF2DMR and H19 was measured in newborn umbilical
cord white blood cells. Associations were assessed between parental tobacco smoking and DNA methylation using linear
mixed models and adjusted for potential confounders.
Results: The DNA methylation levels of IGF2DMR and H19 in the non-smoking group were median (90 % range), 54.0 %
(44.6–62.0), and 30.0 % (25.5–34.0), in the first trimester only smoking group 52.2 % (44.5–61.1) and 30.8 % (27.1–34.1),
and in the continued smoking group 51.6 % (43.9–61.3) and 30.2 % (23.7–34.8), respectively. Continued prenatal maternal
smoking was inversely associated with IGF2DMR methylation (β = −1.03, 95 % CI −1.76; −0.30) in a dose-dependent
manner (P-trend = 0.030). This association seemed to be slightly more profound among newborn girls (β = −1.38, 95 %
CI −2.63; −0.14) than boys (β = −0.72, 95 % CI −1.68; 0.24). H19 methylation was also inversely associated continued
smoking <5 cigarettes/day (β = −0.96, 95 % CI −1.78; −0.14). Moreover, the association between maternal
smoking and newborns small for gestational age seems to be partially explained by IGF2DMR methylation
(β = −0.095, 95 % CI −0.249; −0.018). Among non-smoking mothers, paternal tobacco smoking was not associated
with IGF2DMR or H19 methylation.
Conclusions: Maternal smoking is inversely associated with IGF2DMR methylation in newborns, which can be
one of the underlying mechanisms through which smoking affects fetal growth.
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Impaired fetal growth and low birth weight increase
the risk of short and long-term morbidity and mortal-
ity [1, 2]. A suboptimal prenatal environment contrib-
utes to fetal endocrine and metabolic adaptations with
permanent effects [3, 2]. An important modifiable and
adverse prenatal exposure is tobacco smoking by
parents-to-be. The deleterious effects of maternal to-
bacco smoking on fetal growth and newborn weight
are well-established [4]. The underlying mechanisms
are not fully known but include vasoconstriction, re-
duced placental and fetal perfusion, and hypoxia [5].
Accumulating data suggest that derangements in epi-
genetic fetal and placental (re)programming may be
one of the underlying mechanisms explaining the asso-
ciation between prenatal tobacco smoking and im-
paired fetal growth [6].
Epigenetic alterations are changes in gene expression
potential that are not directly related to the deoxyribo-
nucleic acid (DNA) sequence itself. DNA methylation
modifications are one of the best understood epigenetic
mechanisms [7]. During pregnancy, cells undergo major
epigenetic reprogramming making them more suscep-
tible for derangements during this period [7]. Both ani-
mal and human studies have shown that changes in the
prenatal environment can lead to variations in epigenetic
profiles [8–10]. Previous studies have shown global and
gene specific differences in DNA methylation in different
tissues in children prenatally exposed to tobacco smok-
ing [11–13]. Insulin growth factor 2 (IGF2) and H19 are
maternally and paternally imprinted genes located next
to each other, playing an important role during fetal
growth and development (Additional file 1: Figure S1)
[14–17]. Moreover, the IGF2/H19 locus is a well-studied
region that is known to be regulated through epigenetic
mechanisms and sensitive to environmental exposures
[9]. Previous research demonstrated that men may be
more susceptible to detrimental early prenatal exposures
than women [18].
Less is known about the influence of prenatal paternal
tobacco smoking on gene-specific DNA methylation in
newborns. Moreover, information on paternal tobacco
smoking can be used to elucidate whether an effect on
DNA methylation in newborns is due to the direct
intrauterine effect of maternal smoking.
From this background, we aim to study whether pre-
natal parental tobacco smoking is associated with DNA
methylation of IGF2 differentially methylated region
(DMR) and H19 in umbilical white cord blood cells of
newborns, with a focus on differences in sensitivity
between genders. Furthermore, we examined mediation
of DNA methylation in the association between tobacco
smoking and the risk of being born small for gestational
age (SGA).Results
Maternal and newborns characteristics are presented in
Table 1. Of the included mothers, 9.3 % (n = 47) re-
ported tobacco smoking only in the first trimester and
24.7 % (n = 125) continued smoking during pregnancy.
Mothers who continued tobacco smoking were younger,
lower educated, and less often used a folic acid supple-
ment during the periconception period than mothers
who never smoked during pregnancy. Paternal tobacco
smoking was more frequent in families with mothers
who continued smoking (72.8 % in continued smoking
versus 37.4 % in non-smoking mothers). Median (90 %
range) birth weights of newborns from non-smokers,
first trimester only and continued smoking mothers
were 3500 (2536–4383), 3410 (2154–4219), and 3195
(2348–4081) grams. The median (90 % range) DNA methy-
lation levels of IGF2DMR and H19 were 53.2 % (44.3–61.3)
and 30.1 % (25.6–34.1), respectively. IGF2DMR and H19
were correlated (Pearsons r = 0.147, P value = 0.001). The
DNA methylation levels of IGF2DMR and H19 in the
non-smoking group were median (90 % range), 54.0 %
(44.6–62.0), and 30.0 % (25.5–34.0), in the first trimes-
ter only smoking group 52.2 % (44.5–61.1) and 30.8 %
(27.1–34.1), and in the continued smoking group
51.6 % (43.9–61.3) and 30.2 % (23.7–34.8), respectively.
In addition, the methylation levels of IGF2DMR and
H19 were plotted according to each of the smoking cat-
egories (Additional file 2: Figure S2).
The associations between parental tobacco smoking and
DNA methylation of IGF2DMR and H19 are shown in
Table 2. Although IGF2DMR methylation of mothers who
smoked only during the first trimester showed a tendency
to be lower compared to non-smokers, no significant differ-
ences were observed. However, continued prenatal smoking
was associated with lower IGF2DMR methylation (crude
model, β = −1.14, 95 % CI −1.81; −0.47, P value = 0.001;
adjusted model, β = −1.03, 95 % CI −1.76; −0.30, P value =
0.006). Expressed as relative to the standard deviation, the
difference found in the adjusted model corresponds with a
standardized effect size in DNA methylation of −0.13
standard deviation score (SDS). Of the mothers who
continued smoking, 77.6 % (n = 97) provided information
concerning the amount of cigarettes they smoked, of which
42.3 % (n = 41) reported to have smoked less than five ciga-
rettes per day and 57.7 % (n = 56) reported to have smoked
five or more cigarettes per day. No significant associ-
ation was found between the amount of cigarettes and
IGF2DMR methylation. However, a dose-dependent
association of the number of cigarettes smoked was
assessed in mothers who continued smoking (P value
for trend = 0.030). Although no association was ob-
served between mothers who continued smoking and H19
methylation, a significantly inverse association was revealed
in mothers smoking up to five cigarettes per day (crude
Table 1 Baseline characteristics
Characteristic Prenatal maternal tobacco smoking
No (n = 334) First trimester
only (n = 47)
Continued
All (n = 125) <5 cigarettes per day
(n = 41)




Age at intake (years)a, b 31.5 (22.5–38.1) 30.5 (20.1–38.3) 28.5 (19.0–37.7) 29.4 (20.0–37.5) 28.4 (18.4–39.9) <0.001
Body mass index at
intake (kg/m2)a, b
23.1 (19.5–32.2) 23.2 (19.6–33.1) 23.7 (18.2–32.5) 22.8 (18.2–33.6) 24.8 (18.0–33.9) NS
Education, n (%) <0.001
Primary education 6 (1.8) 4 (8.5) 12 (9.6) 0 (0) 10 (17.9)
Secondary education 134 (40.1) 21 (44.7) 78 (62.4) 23 (56.1) 34 (60.7)
Higher education 193 (57.8) 22 (46.8) 33 (26.4) 17 (41.5) 11 (19.6)
Missing 1 (0.3) 0 (0.0) 2 (1.6) 1 (2.4) 1 (1.8)
Parity (%) NS
0 220 (65.9) 34 (72.3) 82 (65.6) 28 (68.3) 35 (62.5)
≥1 114 (34.1) 13 (27.7) 43 (34.4) 13 (31.7) 21 (37.5)
Folic acid supplement use
during pregnancy, n (%)
<0.001
Start preconception 188 (56.3) 18 (38.3) 29 (23.2) 11 (26.8) 15 (26.8)
Start postconception 84 (25.1) 19 (40.4) 36 (28.8) 13 (31.7) 13 (23.2)
No 25 (7.5) 7 (14.9) 33 (26.4) 10 (24.4) 14 (25)
Missing 37 (11.1) 3 (6.4) 27 (21.6) 7 (17.1) 14 (25)
Paternal smoking, n (%) 125 (37.4) 28 (59.6) 91 (72.8) 14 (34.1) 9 (16.1) <0.001
<5 cigarettes per day 57 (17.1) 9 (19.1) 17 (13.6) 7 (17.1) 17 (30.4)
≥5 cigarettes per day 67 (20.1) 18 (38.3) 73 (58.4) 4 (9.8) 39 (69.6)
Newborns
Boys, n (%) 195 (58.4) 21 (44.7) 81 (64.8) 26 (63.4) 34 (60.7) NS
Birth weighta, b 3500 (2536–4383) 3410 (2154–4219) 3195 (2348–4081) 3175 (2663–4252) 3210 (2334–4150) <0.001
Gestational age at birtha, b 40.3 (37.6–42.0) 40.3 (36.5–41.9) 40.1 (37.1–42.5) 40.6 (37.0–42.9) 40.2 (36.9–42.3) NS
IGF2DMR methylation (%)a 54.0 (44.6–62.0) 52.2 (44.5–61.1) 51.6 (43.9–61.3) 52.0 (44.0–61.2) 51.1 (41.2–63.9) 0.033
H19 methylation (%)1 30.0 (25.5–34.0) 30.8 (27.1–34.1) 30.2 (23.7–34.8) 29.8 (21.5–33.0) 30.2 (23.1–37.0) NS
aValues are presented as median (90 % range) or as number (%)
bMissings; age at intake (n = 0), body mass index at intake (n = 1), gender (n = 0) birth weight (n = 0), gestational age at birth (n = 0)
cANOVA and chi-square tests are used to test differences between the different smoking categories
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adjusted model, β = −0.96, 95 % CI −1.78; −0.14, P value =
0.021). Expressed relative to the standard deviation, the
difference found in the adjusted model corresponds with a
standardized effect size in DNA methylation of −0.13 SDS.
No significant associations were observed in mothers
who reported to have smoked five or more cigarettes
per day with H19 methylation. Among mothers who
did not smoke during pregnancy, information on pre-
natal paternal tobacco smoking was provided by 99.4 %
of the mothers (n = 332/334). Of the fathers who
smoked, 45.6 % (n = 57/125) smoked less than five ciga-
rettes per day and 53.6 % (n = 67/125) smoked five or
more cigarettes per day. No association was observed
between paternal smoking and IGF2DMR or H19methylation. We repeated the analyses after exclusion
of the attention deficit hyperactivity disorder (ADHD)
cases (see Additional file 3: Table S3), which did not
change substantially the effect estimates.
Table 3 shows the associations between maternal to-
bacco smoking and DNA methylation, stratified by gen-
der. In mothers who smoked during the first trimester,
an inverse association among newborn girls was shown
with IGF2DMR methylation (crude model, β = −1.40, 95 %
CI −2.79; −0.01, P value = 0.048), which attenuated in the
adjusted model (β = −1.25, 95 % CI −2.71; 0.21, P value =
0.093). This association was not observed among boys. In
addition, first trimester smoking was positively associ-
ated with H19 methylation among girls but lost signifi-
cance after adjustment (crude model, β = 1.04, 95 % CI
Table 2 Prenatal parental tobacco smoking habits and DNA methylation
IGF2DMR methylation H19 methylation
bètaa 95 % CI P value bètaa 95 % CI P value
Model 1: adjusted for correlations between CpG sites, bisulphite batch, gestational age at birth
Maternal tobacco smoking
No (n = 334) Reference Reference
First trimester only (n = 47) −0.68 −1.67; 0.31 0.178 0.61 −0.13; 1.35 0.108
Continued smoking, all (n = 125) −1.14 −1.81; −0.47 0.001 −0.24 −0.75; 0.26 0.348
<5 cigarettes per day (n = 41) −1.06 −2.13; −0.00 0.050 −0.90 −1.70; −0.11 0.026
≥5 cigarettes per day (n = 56) −1.12 −2.06; −0.18 0.019 −0.13 −0.82; 0.56 0.703
P for trend 0.006 0.298
Paternal tobacco smoking
No (n = 207) Reference Reference
Yes (n = 125) −0.24 −0.96; 0.48 0.519 −0.10 −0.61; 0.41 0.707
<5 cigarettes per day (n = 57) −0.26 −1.22; 0.70 0.597 −0.19 −0.87; 0.50 0.592
≥5 cigarettes per day (n = 67) −0.16 −1.06; 0.73 0.719 −0.04 −0.68; 0.60 0.893
P for trend 0.643 0.795
Model 2: model 1 + maternal characteristics (age, educational level, parity, BMI, periconception folic acid supplement use) and fetal gender
Maternal tobacco smoking
No (n = 334) Reference Reference
First trimester only (n = 47) −0.70 −1.71; 0.31 0.175 0.56 −0.20; 1.32 0.146
Continued smoking, all (n = 125) −1.03 −1.76; −0.30 0.006 −0.37 −0.94; 0.20 0.195
<5 cigarettes per day (n = 41) −1.01 −1.89; 0.10 0.069 −0.96 −1.78; −0.14 0.021
≥5 cigarettes per day (n = 56) −0.89 −2.10; 0.08 0.079 −0.20 −0.93; 0.54 0.602
P for trend 0.030 0.242
Paternal tobacco smoking
No (n = 207) Reference Reference
Yes (n = 125) −0.17 −0.91; 0.58 0.663 −0.23 −0.75; 0.30 0.393
<5 cigarettes per day (n = 57) −0.20 −1.18; 0.77 0.681 −0.23 −0.92; 0.45 0.502
≥5 cigarettes per day (n = 67) −0.07 −1.01; 0.88 0.887 −0.25 −0.91; 0.42 0.463
P for trend 0.809 0.395
Results from linear mixed model analyses with maternal and paternal prenatal tobacco smoking as independent variable and DNA methylation as
dependent variable
aAnalyses were performed with square root transformed methylation data and values are presented as regression coefficients (95 % confidence interval).
Analyses on paternal smoking were restricted to non-smoking mothers
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95 % CI −0.05; 2.03, P value = 0.063). The association be-
tween continued maternal tobacco smoking and IGF2DMR
methylation was slightly more profound among girls (crude
model, β = −1.46, 95 % CI −2.59; −0.33, P value = 0.011;
adjusted model, β = −1.38, 95 % CI −2.63; −0.14, P
value = 0.029) than in boys (crude model, β = −0.89,
95 % CI −1.73; −0.06, P value = 0.037; adjusted model,
β = −0.72, 95 % CI −1.68; 0.24, P value = 0.142).
Associations between maternal tobacco smoking, the
risk of a newborn being SGA, and gene-specific DNA
methylation were analyzed using mediation analyses. We
hypothesized that epigenetic alterations can mediate theassociation between maternal prenatal tobacco smoking
and impaired fetal growth (Fig. 1). The indirect effect, de-
fined as the product of the coefficient for the effect of ma-
ternal tobacco smoking on DNA methylation (path a), and
the coefficient for the effect of DNA methylation on the
risk of a newborns being SGA (path b), was calculated
(Fig. 2). The observed significant effect (β = −0.095, 95 %
CI −0.249; −0.018) substantiates the notion that the asso-
ciation between maternal prenatal smoking and the risk of
a newborn being SGA is partially mediated through
IGF2DMR methylation. The remaining direct effect of
smoking on SGA (c’) seems to be explained by the slightly
younger age and lower educational level of the smoking
Table 3 Prenatal maternal tobacco smoking and DNA methylation, stratified by gender
IGF2DMR methylation H19 methylation
bètaa 95 % CI P value bètaa 95 % CI P value
Model 1: adjusted for correlations between CpG sites, bisulphite batch, gestational age at birth
Boys
No (n = 195) Reference Reference
First trimester only (n = 21) 0.12 −1.33; 1.57 0.870 0.18 −0.95; 1.31 0.754
Continued smoking, all (n = 81) −0.89 −1.73; −0.06 0.037 −0.41 −1.07; 0.25 0.222
P for trend 0.044 0.249
Girls
No (n = 139) Reference Reference
First trimester only (n = 26) −1.40 −2.79; −0.01 0.048 1.04 0.04; 2.03 0.041
Continued smoking, all (n = 44) −1.46 −2.59; −0.33 0.011 −0.10 −0.90; 0.71 0.816
P for trend 0.005 0.817
Model 2: model 1 + maternal characteristics (age, educational level, parity, BMI, periconception folic acid supplement use)
Boys
No (n = 195) Reference Reference
First trimester only (n = 21) 0.15 −1.32; 1.61 0.845 0.14 −1.00; 1.28 0.810
Continued smoking, all (n = 81) −0.72 −1.68; 0.24 0.142 −0.69 1.45; 0.08 0.078
P for trend 0.166 0.098
Girls
No (n = 139) Reference Reference
First trimester only (n = 26) −1.25 −2.71; 0.21 0.093 1.00 −0.05; 2.03 0.063
Continued smoking, all (n = 44) −1.38 −2.63; −0.14 0.029 −0.05 −0.93; 0.83 0.910
P for trend 0.018 0.813
Results from linear mixed model analyses with maternal and parental tobacco smoking as independent variable and DNA methylation as dependent variable,
stratified by gender
aAnalyses were performed with square root transformed methylation data and values are presented as regression coefficients (95 % confidence interval)
Fig. 1 Graphical representation of proposed mediation effect. Panel a illustrates the total effect (path c). Panel b represents the mediation design.
The direct effect is depicted as path c’. The indirect effect (ab) is defined as the product of path a and path b
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Fig. 2 Mediation analyses. Values represent unstandardized beta’s. *P < 0.05
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mass index (BMI) of the mother, nulliparity, and the male




In 506 newborns, derived from a population-based birth
cohort, we examined whether parental tobacco smoking is
associated with IGF2DMR and H19 methylation in umbil-
ical white cord blood cells. After adjustment for con-
founders, continued maternal prenatal tobacco smoking
was associated in a dose-dependent manner with de-
creased IGF2DMR methylation in newborns. This associ-
ation was stronger in newborn girls than boys. Decreased
H19 methylation was also observed in mothers who
continued to smoke <5 cigarettes/day. Prenatal paternal
smoking was not associated with IGF2DMR or H19
methylation. Furthermore, the association between mater-
nal smoking and the increased risk of being SGA may be
partially mediated through IGF2DMR methylation.
Interpretation
Prenatal maternal tobacco smoking has been recognized
as an important and modifiable detrimental exposure and
has repeatedly been associated with disease [4, 19, 5]. Sev-
eral studies have investigated associations between mater-
nal prenatal smoking and global and gene-specific DNA
methylation [20, 6]. Epigenome-wide methylation analyses
revealed methylation changes at birth in newborns whose
mother had smoked during pregnancy [21, 22]. Others in-
vestigated DNA methylation differences at the IGF2/H19
locus in relation to prenatal exposure to maternal tobacco
smoking but found higher IGF2DMR methylation levels in
boys born to smokers compared to non-smokers (+4.7 %
IGF2DMR methylation) [15]. The region analyzed by
Murphy et al. for the IGF2DMR included three CpGdinucleotides upstream of exon 3 (chr 11p15.5; CpG site
1, 2,169,518; CpG site 2, 2,169,515; and CpG site 3,
2,169,499; NCBI Human Genome Build 37/hg19) which
overlapped with the region analyzed in our study (chr
11p15.5; CpG site 3, 2,169,709; CpG site 4, 2,169,660;
CpG site 6/7, 2,169,518/2,169,515; NCBI Human Genome
Build 37/hg19) [15]. The third CpG site analyzed by Mur-
phy et al. overlapped with our eighth CpG site, which was
excluded due to technical issues (see Additional file 4:
Table S4) [15]. For the analyses of H19 DMR, the regions
did not overlap. Other detrimental exposures, such as pre-
natal exposure to famine, have been previously linked to
lower IGF2DMR methylation (−5.2 % IGF2DMR methyla-
tion when periconception exposure to famine), whereas
advantageous exposures, such as periconceptional folic
acid supplement use, have been associated with increased
methylation (+4.5 % IGF2DMR methylation) [9, 8]. Our
findings are also consistent with Guerrero-Preston et al.,
who also reported an inverse association between global
DNA methylation and the nicotine biomarker cotinine
however without stratification for gender [13]. In a previ-
ous study performed in the same population, we showed
that SGA was associated with −1.13 % lower IGF2DMR
methylation [17]. However, further research is warranted
to further elucidate this difference.
In our study, the inverse association between maternal
tobacco smoking from the first trimester onwards and
IGF2DMR methylation seemed to be slightly more
profound in girls. This finding is in contrast to previous
research which demonstrated that boys may be more
susceptible to detrimental exposures than girls [23, 18].
The first days after conception are important for the re-
programming of the epigenome. A limitation of our
study is that we were not able to study difference in pre-
conception and postconception smoke exposure on the
methylation of the IGF2/H19 locus. This warrants fur-
ther research.
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terations mediate the association between maternal to-
bacco smoking and adverse birth outcomes. Our study
supports the notion that DNA methylation can be one
of the mechanisms through which tobacco smoking im-
pairs fetal growth. As nicotine crosses the placenta, it
can directly harm the fetus [24]. Cigarette smoke has
been shown to contain high levels of reactive oxygen
species (ROS) causing oxidative stress [25]. DNA ROS
damage can interfere with the binding of DNA methyl-
transferases (DNMTs) to the DNA, resulting in DNA hy-
pomethylation [26]. Tobacco smoking can also indirectly
damage the fetus through the effects on the placenta.
Nicotine causes vasoconstriction and thus can impair pla-
cental function [27]. Increased vasoconstriction will limit
blood flow and thus the provision of nutrients to the fetus,
which could be compared to the effects of exposure to
famine previously linked to epigenetic effects [9].
Mothers exposed to passive cigarette smoking show in-
creased risks of adverse birth outcomes [28, 29]. There-
fore, the strength of our study is that we were able to
investigate direct intrauterine effects of maternal smoking
by taking into account the effect of prenatal smoking of
both parents. The effect of paternal smoking was not sta-
tistically significant and smaller than the effect of maternal
smoking. This suggests that the observed effect is largely
due to direct intrauterine effects of maternal smoking and
not to unmeasured environmental factors as the mother
and father are likely to share their environment, which is
substantiated by a recent study [30].
DNA methylation is believed to be relatively stable
throughout life, but these patterns are reprogrammed sig-
nificantly during fetal and early postnatal life [7]. There-
fore, it is assumed that the epigenome is susceptible for
derangements during developmental stages when adverse
prenatal environmental exposures can permanently alter
methylation in the offspring. The periconception period is
of particular importance, as epigenetic reprogramming
takes most place during this period [7]. Our findings sup-
port the notion that changes in DNA methylation at the
IGF2DMR are being established during the periconception
period, as the methylation levels of mothers who quit
smoking during the first trimester showed a tendency to
be lower than in non-smokers. The non-significance may
also be explained by small numbers of mothers who quit
smoking during the first trimester. However, a larger effect
was observed in mothers who continued to smoke during
pregnancy, indicating that these effects are not limited to
the periconception period.
Strengths and limitations
This study was embedded in a large cohort from which
a selection of Dutch newborn were studied. Selective
participation did occur to some degree, as participatingmothers were younger, more often single and smokers,
and newborns were more often boys. This selection could
have affected the external validity and generalizability of
the study, especially when the associations would differ
between the study population without and with the ex-
cluded newborns. This is difficult to ascertain, as the asso-
ciations in the excluded group are unknown.
The study was based on a prospective data collection
starting in early pregnancy. Detailed information was
available on prenatal parental tobacco smoking habits,
which enabled studying both trimester specific and
dose-response associations. Although the use of ques-
tionnaires seems to be a valid method misclassification
could have occurred, mostly leading to underreporting
of tobacco smoking and therefore an underestimation of
our estimates [31]. Lastly, although analyses were ad-
justed for potential confounders, the possibility of re-
sidual confounding cannot completely be excluded.
This study showed modest changes in DNA methylation
in mothers who continued to smoke during pregnancy.
Replication of these results is warranted. We were not able
to assess whether the DNA methylation variations also re-
sulted in changes in expression and long-term functional
effects, although this has recently been shown in studies
of others [32–34]. DNA methylation was measured in um-
bilical cord white blood cells and not in other tissues. It
could be argued that DNA methylation patterns differ
across various tissues [35, 36]. However, DNA methylation
of imprinted genes such as IGF2DMR/H19 is believed to
be largely comparable in different tissues. For example,
DNA methylation patterns of IGF2DMR in blood and in
buccal cells and colon tissue showed moderate correla-
tions [35, 37, 36]. We emphasize that it remains important
to establish correlations between DNA methylation in
peripheral tissues, e.g., blood, and tissues that are dir-
ectly involved in the disease. However, in human epi-
demiological studies, it is commonly accepted to use
blood or buccal samples due to relatively poor accessi-
bility of other tissues.Conclusions
Our study shows an inverse association of maternal pre-
natal tobacco smoking and its dose and duration with
IGF2DMR methylation in newborns. IGF2DMR methyla-
tion may mediate the association between maternal to-
bacco smoking and the risk of a newborn born SGA,
supporting the notion that epigenetic alterations could be
one of the mechanisms through which smoking affects
fetal growth. The understanding how epigenetic control
depends on early exposure may shed light on the link be-
tween fetal development and health over the life course.
Our research emphasizes the importance to quit smoking
preferably in the preconception period, although our data
Bouwland-Both et al. Clinical Epigenetics  (2015) 7:83 Page 8 of 11also shows that the advantageous effects of quitting smok-
ing may not be limited to this period.
Methods
Design and study population
This study was embedded in the Generation R Study
Rotterdam, the Netherlands, a population-based prospect-
ive cohort study from early pregnancy onwards [38]. The
study has been approved by the Medical Ethical Commit-
tee of the Erasmus Medical Center in Rotterdam (MEC
198.782/2001/31). Written informed consent was obtained
from all participating mothers for both maternal and child
data. Mothers were enrolled during pregnancy, between
2001 and 2006. In total, 8880 mothers were enrolled dur-
ing pregnancy.
For the present study, analyses were restricted to Dutch
newborns, which were based on the country of birth of
the parents and grandparents (n = 4882) [38]. In addition,
newborns were selected with DNA extracted from umbil-
ical cord white blood cells available (n = 3127). DNA
methylation measurements were limited to 540 newborns
due to logistic reasons. The current study is part of a pro-
ject, in which we investigate the hypothesis that both SGA
and children with ADHD have a shared causality in DNA
methylation of especially imprinted fetal growth genes.
The sampling strategy was to oversample the children
born SGA or diagnosed with ADHD to improve the
power of the analyses. Therefore, all infants born with a
gestational age and sex-adjusted birth weight below −2
SDS (n = 69) were selected for analysis. Also, 92 children
were included with ADHD based on parent interview
Diagnostic Inventory of Screening Children or Child Be-
havior Checklist teacher report at age 6. Two of the in-
fants with ADHD were also born with a gestational age
and sex-adjusted birth weight below −2 SDS. The
remaining 381 control newborns were randomly selected.
Controls were born with a gestational age and sex-
adjusted birth weight above −2 SDS. Of the 540 new-
borns, data on parental smoking habits was available in
93.7 % (n = 506). The total population for analysis was
506 children (65 newborns born SGA, 88 cases of
ADHD, and 441 control newborns). Characteristics of
the included and excluded mothers and newborns were
compared. Included versus excluded mothers were
younger (30.3 years versus 31.1 years, P value < 0.001),
smoked more often during pregnancy (32.9 % versus
26.0 % , P value < 0.001), and were more often single
(10.9 % versus 8.4 %, P value = 0.02). Included versus
excluded newborns were more often male (58.7 % ver-
sus 49.7 (P value < 0.001)). However, included and ex-
cluded participants were similar in terms of maternal
BMI, maternal educational level, parity, folic acid sup-
plement and alcohol use, and APGAR score after 1 and
5 min (all P > 0.05).Prenatal parental tobacco smoking habits
Information regarding maternal tobacco smoking was ob-
tained by self-administered questionnaires sent in each tri-
mester of pregnancy. Active maternal tobacco smoking at
enrolment was assessed by asking the mother whether she
smoked during pregnancy (no tobacco smoking, first tri-
mester only tobacco smoking, continued tobacco smoking
during pregnancy). This questionnaire was sent to all
mothers, regardless of their gestational age at enrolment.
In the second and third questionnaires, mothers were
asked whether they smoked in the previous 2 months (no,
yes). Mothers who reported that they did not smoke or
only smoked during the first trimester, but still reported
smoking in the second or third questionnaire, were classi-
fied as continuous smokers. Among the mothers who con-
tinuously smoked during pregnancy, the number of
cigarettes were assessed and classified as (1) less than five
cigarettes a day and (2) five or more cigarettes a day.
Dose-response analyses for continuous smokers were
based on the third trimester questionnaires. Prenatal
paternal tobacco smoking was assessed at enrolment by
asking the mother whether the father smoked during
pregnancy (no, yes, do not know). Similar information
was provided by the father in a subset of the partici-
pants (n = 433). Agreement between the two assess-
ments was good (sensitivity = 92 %, specificity = 95 %).
As more data was available from the mother question-
naire compared to the father questionnaire (6.7 % miss-
ing versus 19.8 % missing, respectively), data obtained
from the mother’s questionnaire was used.
Assessment of DNA methylation
Genomic DNA was isolated from cord blood samples
at birth as previously described [39]. We assessed DNA
methylation of two imprinted loci, namely IGF2DMR
and H19DMR. These loci were chosen based on their
previously shown features of epigenetic regulation and
their susceptibility for to environmental exposures [40].
Details of the measured amplicons can be found in
Additional file 4: Table S4. Isolated genomic DNA
(500 ng) was treated with sodium bisulphite for 16 h using
the EZ-96 DNA methylation kit (Shallow) (Zymo Re-
search, Irvine, CA, USA), according to the manufactures’
protocol. Samples were randomly distributed on six 96-
well plates. The bisulphite treatment was followed by
polymerase chain reaction (PCR) amplification, fragmen-
tation after reverse transcription, and analysis on a mass
spectrometer, according to the manufactures’ protocol
(MassARRAY EpiTYPER, Sequenom, Inc, San Diego, CA,
USA). This generated mass signal patterns that were
translated into quantitative DNA methylation levels of dif-
ferent CpG sites of the selected loci by MassARRAY Epi-
TYPER Analyzer software (v1.0, build1.0.6.88 Sequenom,
Inc, San Diego, CA, USA) [41, 42]. Fragments containing
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subsequent steps were performed in triplicate.
Data quality control for methylation consisted of exclu-
sion of CpG units with too low or too high mass or CpG
units with overlapping or duplicate RNA fragments (e.g.,
silent signals) were excluded from further analysis. Further-
more, at least two out of three of the replicate measure-
ments per CpG unit had to be successful, the standard
deviation of the duplicates or triplicates had to be ≤0.10,
and the success rate per CpG unit had to be ≥75 %. Also,
from previous research it is known that PCR bias can
occur with quantitative DNA methylation measurements
methods [43]. To address this potential problem, we
created standard curves constructed from DNA with low
and high methylation (EpigenDx, Worcester, MA, USA) in
steps of 10 % methylation difference on both amplicons.
CpGs showing irregularities were excluded from the ana-
lyses. Last, CpG units with interference of single nucleotide
polymorphisms (CEU) with a frequency of >5 % were also
excluded, as this could change the weight of the CpG unit
and therefore interfere with the measurement. Details
concerning the success rate of the amplicons can be found
in Additional file 5: Table S5.
Covariates
From self-administered questionnaires, data was available
on maternal age and maternal educational level, parity, and
folic acid supplement use before and during pregnancy.
Maternal education level was assessed by the highest
completed education and classified as (1) none/primary
or “low”, (2) secondary or “medium”, and (3) college/
university or “high”. Parity was classified as (1) nulliparous
and (2) multiparous. Folic acid supplement use was catego-
rized into (1) folic acid supplement use (pre- or post-
conception start) and (2) no folic acid supplement use.
At enrolment (median 13.5 weeks, 90 % range 10.7–
21.6), maternal weight and height were measured to
calculate BMI (kg/m2). Information concerning date of
birth, offspring sexm, and birth weight was obtained
from community midwives and hospital registries.
Statistical analyses
Differences in maternal or newborns characteristics be-
tween maternal tobacco smoking categories were tested
using ANOVA and chi-square tests. Thereafter, linear
mixed models were used to examine the associations be-
tween maternal or paternal tobacco smoking (independent
variable) and DNA methylation (dependent variable). This
model was chosen as it can account for correlation
between CpG dinucleotides, incorporates relevant adjust-
ments within the models, and has the ability to accommo-
date missing data. The restricted maximum likelihood
method was used for the model fitting. DNA methylation
was treated as a continuous variable. To achievenormality, DNA methylation was square root transformed.
Outliers per CpG (>3SDS) were excluded from further
analysis. For all analyses, subject/person identifier was
added as random effect and bisulphite batch and CpG site
were added as fixed effects. In the crude analyses, mater-
nal and paternal tobacco smoking were both entered as a
fixed effects in separate models. In the adjusted analyses,
potential confounders were additionally entered to the
model at the same time as fixed effects.
Since maternal and paternal smoking are correlated,
investigating paternal smoking among all mothers would
overestimate the effect of paternal smoking if direct
intrauterine mechanisms were present. Therefore, the
association between paternal smoking and DNA methy-
lation was examined among mothers who did not smoke
during pregnancy. Prenatal exposures have shown to
alter IGF2DMR methylation differently according to sex.
[18] Therefore, the association between maternal to-
bacco smoking and DNA methylation was assessed in
both boys and girls. The analyses were also repeated
with exclusion of the ADHD (n = 88) cases. Two new-
borns were classified as both ADHD and SGA.
Additionally, we performed a mediation analyses to
investigate whether DNA methylation of either IGF2DMR
or H19 mediates the association between maternal tobacco
smoking and the risk of a newborns being born SGA. The
direct and indirect effects between the dependent (SGA)
and independent variable (maternal tobacco smoking) as
well as the mediator (DNA methylation) were tested (Fig. 1)
using a bootstrap approach (1000 samples) described by
Preacher and Hayes [44].
Missing data of potential confounders (maternal edu-
cational level (0.6 %), maternal BMI (0.2 %), and mater-
nal folic acid supplement use (13.2 %) were completed
using the Markov-Chain-Monte-Carlo multiple imput-
ation technique [45]. Ten imputed datasets were created.
The linear mixed model analyses were performed using
the data measured in triplicates including imputed miss-
ing data. Overall, the effect estimates using the imputed
dataset were slightly smaller compared to the original
dataset. All analyses were performed using the Statistical
Package for the Social Sciences version 21.0 for
Windows (SPSS Inc, Chicago, IL, USA).
Additional files
Additional file 1: Figure S1. Graphical representation of the IGF2DMR
locus.
Additional file 2: Figure S2. Graphical representation of the
Methylation levels of IGF2DMR and H19.
Additional file 3: Table S3. Parental tobacco smoking habits and DNA
methylation, with exclusion of ADHD cases. Results from linear mixed
model analyses with maternal or paternal tobacco smoking as
independent variable and DNA methylation as dependent variable.
1Analyses were performed with square root transformed methylation
Bouwland-Both et al. Clinical Epigenetics  (2015) 7:83 Page 10 of 11data and values are presented as regression coefficients (95 % confidence
interval). Analyses on paternal smoking were restricted to non-smoking
mothers.
Additional file 4: Table S4. Details of measured amplicons and PCR
primers. 1 Genome built: GRch 37.67. 2 Forward and reverse primer that
will amplify the bisulphite converted genomic DNA. According to the
MassARRAY EpiTYPER technology, taqs were added to the 5'end of the
primers. Forward primer: 10mer spacer tag is added at the 5′ primer end
with the following sequence: 5′-AGGAAGAGAG + primer. Reverse primer:
T7 promoter is added to the 5′ primer end with the following sequence:
5′-CAGTAATACGACTCACTATAGGGAGAAGGCT + primer.
Additional file 5: Table S5. Details quality control.
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